Efficacy of mesalazine in children with moderate to severe alopecia areata: case series of 18 patients.

An Bras Dermatol · 2023 · PMC10589479 · PMID 37407332

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The patients were classified into four groups according to the percentage of reduction in the SALT score: 5% to 25% (weak response), 26% to 50% (moderate response), 51% to 75% (significant response), and 76% to 100 % (highly significant response).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.